Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
114.00    2.50 (2.24%)
Bid:
112.00
Ask:
116.00
Spread: 4.00 (3.571%)
Market Cap: £68.59m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Collaborations with VMWare and Imagination

13 Jun 2017 07:00

RNS Number : 8678H
Intercede Group PLC
13 June 2017
 

 

13 June 2017

INTERCEDE GROUP plc

("Intercede", or the "Group")

Collaborations with VMWare and Imagination

Intercede, the leading specialist in digital identity, credential management and secure mobility, is pleased to announce that it is collaborating with VMWare and Imagination on two separate, significant projects utilising Intercede's leading MyID and MyTAM software.

MyID is now available for VMware Workspace ONE and VMware AirWatch to provide U.S. Federal Government employees with secure remote access to mail, browsers and other apps on their mobile devices. To access this capability, federal government employees can use existing Personal Identity Verification (PIV) smart cards at a self-service kiosk to authenticate to the system to provision keys and certificates to their mobile devices.

Users are able to leverage Intercede's MyID technology and mobile software development kit (SDK) through a derived credentials solution for secure mobility, which provides increased mobile credentialing capability in compliance with stringent security standards for strong authentication and mobile working (FIPS 201-2 / Special Publication 800-157). More details of this collaboration can be found at https://www.intercede.com/news/intercede-collaborates-with-vmware-to-offer-secure-device-based-mobile-solution-for-u.s.-federal-government/.

Commenting on the VMWare collaboration, Richard Parris, Chairman & CEO of Intercede, said;

"Government is a highly regulated industry and one that cannot afford to be the victim of easily avoided data breaches or cyber hacks. The repercussions of poor authentication for a government department could be serious and far-reaching, which means security should never be taken lightly. Allowing customers to leverage the capabilities of VMware AirWatch and Intercede solutions is low impact to the user, easy to use and will assist government departments in managing who has access to privileged data."

Intercede and Imagination are providing a demonstration of the 'Trust Continuum' at BT's Innovation 2017 event. The demonstration focuses on how systems-on-chips (SoCs) for home gateway routers can be architected to address the growing security and management challenges presented by the proliferation of Internet of Things (IoT) devices, services and technologies entering the home. It is based on a MIPS-based platform which supports multiple isolated Trusted Runtime Environments (TREs) where services, including the network communication standards they rely upon, can be provisioned and managed by the operator. This is enabled by the powerful hardware virtualization capabilities of the MIPS CPU and the security-focused evolution of Intercede's MyTAM® client and mobile app, which enables service providers to dynamically created TREs and to deploy trusted applications directly into them.

More details of Intercede's contribution to BT Innovation 2017 can be found at https://www.intercede.com/news/bt-intercede-and-imagination-collaborate-on-iot-security/.

Richard Parris, Chairman & CEO of Intercede, commented on Intercede's work with Imagination;

"This is another example of how Intercede's software is forming a vital component of key eco-systems, both now and for future development. Systems-on-Chips will be integral to the Internet of Things, particularly in light of the growing management and security issues thrown up by the proliferation of IoT devices, services and technologies entering the home."

 

Contact

Intercede Group plc

Tel: +44 (0) 1455 558 111

Richard Parris

Chairman & Chief Executive

Andrew Walker

Finance Director

finnCap

Tel: +44 (0) 20 7220 0500

Stuart Andrews

Corporate Finance

Simon Hicks

Corporate Finance

Steve Norcross

Corporate Broking

Capital Access Group

Tel: +44 (0) 20 3763 3400

Scott Fulton

Media

Ed Welsby

Investors

 

About Intercede

Intercede is a software and service company specializing in identity, credential management and secure mobility. Its solutions create a foundation of trust between connected people, devices and apps and combine expertise with innovation to provide world-class cybersecurity. Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. Intercede's product portfolio includes MyID, an identity and credential management system that assigns trusted digital identities to employees citizens and machines. In 2015, Intercede launched MyTAM, enabling trusted applications to be loaded into a mobile device's Trusted Execution Environment (TEE), providing hardware-level security for Android apps. In 2016, Intercede launched RapID, a secure, easy to implement authentication service for mobile apps and cloud services to completely eliminate the need for passwords.

For more information visit: www.intercede.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUUSNRBNANAAR
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report
26th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.